Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
4.905
+0.265 (5.64%)
Nov 21, 2024, 1:48 PM EST - Market open
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for FENC stock have an average target of 14, with a low estimate of 13 and a high estimate of 15. The average target predicts an increase of 185.42% from the current stock price of 4.91.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 22, 2024.
Analyst Ratings
The average analyst rating for FENC stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +165.04% | Aug 22, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +205.81% | Aug 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +246.59% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +205.81% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +266.97% | Apr 4, 2024 |
Financial Forecast
Revenue This Year
46.01M
from 21.25M
Increased by 116.50%
Revenue Next Year
54.06M
from 46.01M
Increased by 17.49%
EPS This Year
0.15
from -0.60
EPS Next Year
0.38
from 0.15
Increased by 152.54%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 59.5M | 64.5M | 75.0M | ||
| Avg | 46.0M | 54.1M | 70.4M | ||
| Low | 28.7M | 42.9M | 65.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 180.2% | 40.2% | 38.8% | ||
| Avg | 116.5% | 17.5% | 30.2% | ||
| Low | 34.8% | -6.7% | 20.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.30 | 0.98 | 2.46 | ||
| Avg | 0.15 | 0.38 | 2.37 | ||
| Low | -0.05 | -0.04 | 2.26 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 549.1% | 546.7% | ||
| Avg | - | 152.5% | 524.2% | ||
| Low | - | - | 495.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.